World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
56
Citations
12553
World Ranking
3702
National Ranking
1705

Scott I. Abrams publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Scott I. Abrams sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 245 publications — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Scott I. Abrams D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Scott I. Abrams sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 56 D-Index — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Scott I. Abrams is affiliated with the Roswell Park Cancer Institute in the United States. Their research extensively covers multiple aspects of cancer biology, immunology, and molecular biology, with a focus on cancer immunotherapy and immune system interactions within the tumor microenvironment.

The primary fields of study for this scientist include Medicine, Immunology and Microbiology, and Biochemistry, Genetics and Molecular Biology. Their subfields of expertise delve into Immunology, Oncology, Molecular Biology, Cancer Research, and Pulmonary and Respiratory Medicine.

Among the main topics explored in their research are:

  • Cancer Immunotherapy and Biomarkers
  • Immune cells in cancer
  • Immunotherapy and Immune Responses
  • Immune Cell Function and Interaction
  • Cancer Cells and Metastasis
  • CAR-T cell therapy research
  • Cancer, Hypoxia, and Metabolism

Scott I. Abrams has contributed to a number of scientific papers, some of the recent publications being:

  • Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer, 2022, Cancer Cell
  • Platelet glycoprotein VI promotes metastasis through interaction with cancer cell-derived Galectin-3, 2020, Blood
  • Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1s, 2020, Nature Communications
  • β2-adrenergic receptor signaling regulates metabolic pathways critical to myeloid-derived suppressor cell function within the TME, 2021, Cell Reports
  • Breast Tumor Microenvironment in Black Women: A Distinct Signature of CD8+ T-Cell Exhaustion, 2020, JNCI Journal of the National Cancer Institute

Their frequent collaborators include:

  • Jason B. Muhitch
  • Brian Morreale
  • Fumito Ito
  • Kazuaki Takabe
  • Mark D. Long

Scott I. Abrams publishes regularly in several scientific journals. Notable frequent publication venues are:

  • Cancer Research
  • The Journal of Immunology
  • Annals of Surgical Oncology
  • Journal for ImmunoTherapy of Cancer
  • bioRxiv (Cold Spring Harbor Laboratory)

Best Publications

  • A2A adenosine receptor protects tumors from antitumor T cells

    Akio Ohta;Elieser Gorelik;Simon J. Prasad;Franca Ronchese

  • Irradiation of tumor cells up-regulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapy

    Mala Chakraborty;Scott I. Abrams;Kevin Camphausen;Kebin Liu

  • External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing.

    Mala Chakraborty;Scott I. Abrams;C. Norman Coleman;Kevin Camphausen

  • Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer.

    Unknown

  • Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis

    Jeremy D. Waight;Colleen Netherby;Mary L. Hensen;Austin Miller

  • Baseline tumor growth and immune control in laboratory mice are significantly influenced by subthermoneutral housing temperature

    Kathleen M. Kokolus;Maegan L. Capitano;Chen-Ting Lee;Jason W.-L. Eng

  • An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion

    John D. Klement;Amy V. Paschall;Amy V. Paschall;Priscilla S. Redd;Priscilla S. Redd;Mohammed L. Ibrahim

  • Tumor-Derived G-CSF Facilitates Neoplastic Growth through a Granulocytic Myeloid-Derived Suppressor Cell-Dependent Mechanism

    Jeremy D. Waight;Qiang Hu;Austin Miller;Song Liu

  • Antitumor Activity and Immune Responses Induced by a Recombinant Carcinoembryonic Antigen-Vaccinia Virus Vaccine

    Judy Kantor;Kari Irvine;Scott Abrams;Howard Kaufman

  • β2 adrenergic receptor–mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cells

    Hemn Mohammadpour;Cameron R. MacDonald;Guanxi Qiao;Minhui Chen

  • β-adrenergic signaling in mice housed at standard temperatures suppresses an effector phenotype in CD8+ T cells and undermines checkpoint inhibitor therapy

    Mark J. Bucsek;Guanxi Qiao;Cameron R. MacDonald;Thejaswini Giridharan

  • Immune Response to a Carcinoembryonic Antigen Polynucleotide Vaccine

    Robert M. Conry;Albert F. LoBuglio;Judith Kantor;Jeffrey Schlom

  • Cancer in primary immunodeficiency diseases: Cancer incidence in the United States Immune Deficiency Network Registry

    Paul C. Mayor;Kevin H. Eng;Kelly L. Singel;Scott I. Abrams

  • How tumours escape mass destruction

    Trina Stewart;S.I. Abrams;S.I. Abrams

  • Induction of Antitumor Immunity by Recombinant Vaccinia Viruses Expressing B7-1 or B7-2 Costimulatory Molecules

    James W. Hodge;Scott Abrams;Jeffrey Schlom;Judy A. Kantor

  • Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases

    Margaret Gil;Mukund Seshadri;Marcin P. Komorowski;Scott I. Abrams

  • Bortezomib and Depsipeptide Sensitize Tumors to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand: A Novel Method to Potentiate Natural Killer Cell Tumor Cytotoxicity

    Andreas Lundqvist;Scott I. Abrams;David S. Schrump;Gauri Alvarez

  • A phase I vaccine trial with peptides reflecting ras oncogene mutations of solid tumors.

    S N Khleif;S I Abrams;J M Hamilton;E Bergmann-Leitner

  • Immunogenicity and safety of a recombinant vaccinia virus vaccine expressing the carcinoembryonic antigen gene in a nonhuman primate.

    J. Kantor;K. Irvine;S. Abrams;P. Snoy

  • Platelet glycoprotein VI promotes metastasis through interaction with cancer cell-derived galectin-3

    Elmina Mammadova-Bach;Jesus Gil-Pulido;Edita Sarukhanyan;Philipp Burkard

  • Admixture of a Recombinant Vaccinia Virus Containing the Gene for the Costimulatory Molecule B7 and a Recombinant Vaccinia Virus Containing a Tumor-associated Antigen Gene Results in Enhanced Specific T-Cell Responses and Antitumor Immunity

    J W Hodge;J P McLaughlin;S I Abrams;W L Shupert

  • Treatment of human colon carcinoma cell lines with anti-neoplastic agents enhances their lytic sensitivity to antigen-specific CD8+ cytotoxic T lymphocytes

    Elke S. Bergmann-Leitner;Scott I. Abrams

Frequent Co-Authors

Kebin Liu
Kebin Liu Augusta University
Jeffrey Schlom
Jeffrey Schlom National Institutes of Health
Brahm H. Segal
Brahm H. Segal Roswell Park Cancer Institute
Kunle Odunsi
Kunle Odunsi Roswell Park Cancer Institute
Elizabeth A. Repasky
Elizabeth A. Repasky Roswell Park Cancer Institute
James W. Hodge
James W. Hodge National Institutes of Health
Kelvin P. Lee
Kelvin P. Lee Roswell Park Comprehensive Cancer Center
Keiko Ozato
Keiko Ozato Eunice Kennedy Shriver National Institute of Child Health and Human Development
Paul K. Wallace
Paul K. Wallace Roswell Park Cancer Institute
Agnieszka K. Witkiewicz
Agnieszka K. Witkiewicz Roswell Park Cancer Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology can open doors to diverse healthcare roles, especially when complemented by advanced nursing programs. Many students interested in integrating immunology with clinical practice explore specialized pathways such as psychiatric nursing. For those considering further education, exploring the top psychiatric mental health nurse practitioner programs online can provide valuable insights into quality education matched with strong clinical opportunities.

Cost is often a significant factor when choosing a program. Prospective students may find it helpful to compare options through resources like cheapest psychiatric nurse practitioner programs, ensuring they get quality education without excessive financial burden.

After completing advanced degrees such as a Doctor of Nursing Practice (DNP), understanding the expected dnp salary by state helps in making informed career decisions, effectively aligning specialization with potential earnings and geographic preferences.

For those aiming to deepen their clinical skills, transitioning to more specialized roles is possible. Programs like acute care nurse practitioner programs offer a pathway to broaden expertise, allowing immunology graduates to impact acute care settings directly.

Best Scientists Citing Scott I. Abrams

Trending Scientists

Recently Published Articles